Effects of a surfactant-based gel on acute and chronic paediatric wounds: A panel discussion and case series

Robert Kirsner, Rene Amaya, Kathryn Bass, Vita Boyar, Guido Ciprandi, Paul M. Glat, Steven L. Percival, Marco Romanelli, Timothy P. Pittinger

Research output: Contribution to journalArticle

Abstract

On 20 November 2018, following the International Society for Paediatric Wound Care conference, a closed panel meeting took place in which the use of a surfactant-based gel (PluroGel (PMM), Medline Industries, Illinois, US) in paediatric wound care was discussed. The authors shared their experiences, thoughts, experimental data and clinical results. The panel identified the need for a product that can gently cleanse paediatric wounds and remove devitalised tissue without causing discomfort or skin reactions, as well as potentially promote healing. In adults, PMM has been shown to assist healing by hydrating the wound, controlling exudate and debriding non-viable tissue. Islands of neo-epithelium have also been reported to appear rapidly in different parts of the wound bed. No adverse effects on these proliferating cells have been observed. In vitro data suggest that PMM can remove biofilm, as well as potentially promote healing through cell salvage. The panel, therefore, set out to discuss their experiences of using PMM in the paediatric patients and to establish a consensus on the indications for its use and application in this population. This article will describe the main outcomes of that discussion and present case studies from paediatric patients with a variety of wound types, who were treated with PMM by members of the panel. Declaration of interest: This paper is based on a closed round table discussion held in November 2018. Medline Industries provided MA Healthcare with financial support to prepare the draft paper for publication. All of the authors, except GC, accepted an honorarium from Medline Industries for their participation. RSK, SLP and KDB have received research grants from Medline. RSK, RA, KDB, VB, PMG, SLP, MR, and TP are, or have been, consultants for Medline Industries. GC has no interests to declare.

Original languageEnglish (US)
Pages (from-to)398-408
Number of pages11
JournalJournal of Wound Care
Volume28
Issue number6
DOIs
StatePublished - Jun 2 2019

Fingerprint

Surface-Active Agents
Gels
Pediatrics
Industry
Wounds and Injuries
Financial Support
Organized Financing
Exudates and Transudates
Biofilms
Consultants
Islands
Wound Healing
Publications
Epithelium
Delivery of Health Care
Skin
Research
Population

Keywords

  • Cell repair
  • Debridement
  • Paediatric
  • Pain reduction
  • PluroGel
  • Wound cleansing
  • Wound healing

ASJC Scopus subject areas

  • Fundamentals and skills
  • Nursing (miscellaneous)

Cite this

Effects of a surfactant-based gel on acute and chronic paediatric wounds : A panel discussion and case series. / Kirsner, Robert; Amaya, Rene; Bass, Kathryn; Boyar, Vita; Ciprandi, Guido; Glat, Paul M.; Percival, Steven L.; Romanelli, Marco; Pittinger, Timothy P.

In: Journal of Wound Care, Vol. 28, No. 6, 02.06.2019, p. 398-408.

Research output: Contribution to journalArticle

Kirsner, R, Amaya, R, Bass, K, Boyar, V, Ciprandi, G, Glat, PM, Percival, SL, Romanelli, M & Pittinger, TP 2019, 'Effects of a surfactant-based gel on acute and chronic paediatric wounds: A panel discussion and case series', Journal of Wound Care, vol. 28, no. 6, pp. 398-408. https://doi.org/10.12968/jowc.2019.28.6.398
Kirsner, Robert ; Amaya, Rene ; Bass, Kathryn ; Boyar, Vita ; Ciprandi, Guido ; Glat, Paul M. ; Percival, Steven L. ; Romanelli, Marco ; Pittinger, Timothy P. / Effects of a surfactant-based gel on acute and chronic paediatric wounds : A panel discussion and case series. In: Journal of Wound Care. 2019 ; Vol. 28, No. 6. pp. 398-408.
@article{5dd6e68936ab4c5b866d10f18d5a1ab3,
title = "Effects of a surfactant-based gel on acute and chronic paediatric wounds: A panel discussion and case series",
abstract = "On 20 November 2018, following the International Society for Paediatric Wound Care conference, a closed panel meeting took place in which the use of a surfactant-based gel (PluroGel (PMM), Medline Industries, Illinois, US) in paediatric wound care was discussed. The authors shared their experiences, thoughts, experimental data and clinical results. The panel identified the need for a product that can gently cleanse paediatric wounds and remove devitalised tissue without causing discomfort or skin reactions, as well as potentially promote healing. In adults, PMM has been shown to assist healing by hydrating the wound, controlling exudate and debriding non-viable tissue. Islands of neo-epithelium have also been reported to appear rapidly in different parts of the wound bed. No adverse effects on these proliferating cells have been observed. In vitro data suggest that PMM can remove biofilm, as well as potentially promote healing through cell salvage. The panel, therefore, set out to discuss their experiences of using PMM in the paediatric patients and to establish a consensus on the indications for its use and application in this population. This article will describe the main outcomes of that discussion and present case studies from paediatric patients with a variety of wound types, who were treated with PMM by members of the panel. Declaration of interest: This paper is based on a closed round table discussion held in November 2018. Medline Industries provided MA Healthcare with financial support to prepare the draft paper for publication. All of the authors, except GC, accepted an honorarium from Medline Industries for their participation. RSK, SLP and KDB have received research grants from Medline. RSK, RA, KDB, VB, PMG, SLP, MR, and TP are, or have been, consultants for Medline Industries. GC has no interests to declare.",
keywords = "Cell repair, Debridement, Paediatric, Pain reduction, PluroGel, Wound cleansing, Wound healing",
author = "Robert Kirsner and Rene Amaya and Kathryn Bass and Vita Boyar and Guido Ciprandi and Glat, {Paul M.} and Percival, {Steven L.} and Marco Romanelli and Pittinger, {Timothy P.}",
year = "2019",
month = "6",
day = "2",
doi = "10.12968/jowc.2019.28.6.398",
language = "English (US)",
volume = "28",
pages = "398--408",
journal = "Journal of wound care",
issn = "0969-0700",
publisher = "MA Healthcare Ltd",
number = "6",

}

TY - JOUR

T1 - Effects of a surfactant-based gel on acute and chronic paediatric wounds

T2 - A panel discussion and case series

AU - Kirsner, Robert

AU - Amaya, Rene

AU - Bass, Kathryn

AU - Boyar, Vita

AU - Ciprandi, Guido

AU - Glat, Paul M.

AU - Percival, Steven L.

AU - Romanelli, Marco

AU - Pittinger, Timothy P.

PY - 2019/6/2

Y1 - 2019/6/2

N2 - On 20 November 2018, following the International Society for Paediatric Wound Care conference, a closed panel meeting took place in which the use of a surfactant-based gel (PluroGel (PMM), Medline Industries, Illinois, US) in paediatric wound care was discussed. The authors shared their experiences, thoughts, experimental data and clinical results. The panel identified the need for a product that can gently cleanse paediatric wounds and remove devitalised tissue without causing discomfort or skin reactions, as well as potentially promote healing. In adults, PMM has been shown to assist healing by hydrating the wound, controlling exudate and debriding non-viable tissue. Islands of neo-epithelium have also been reported to appear rapidly in different parts of the wound bed. No adverse effects on these proliferating cells have been observed. In vitro data suggest that PMM can remove biofilm, as well as potentially promote healing through cell salvage. The panel, therefore, set out to discuss their experiences of using PMM in the paediatric patients and to establish a consensus on the indications for its use and application in this population. This article will describe the main outcomes of that discussion and present case studies from paediatric patients with a variety of wound types, who were treated with PMM by members of the panel. Declaration of interest: This paper is based on a closed round table discussion held in November 2018. Medline Industries provided MA Healthcare with financial support to prepare the draft paper for publication. All of the authors, except GC, accepted an honorarium from Medline Industries for their participation. RSK, SLP and KDB have received research grants from Medline. RSK, RA, KDB, VB, PMG, SLP, MR, and TP are, or have been, consultants for Medline Industries. GC has no interests to declare.

AB - On 20 November 2018, following the International Society for Paediatric Wound Care conference, a closed panel meeting took place in which the use of a surfactant-based gel (PluroGel (PMM), Medline Industries, Illinois, US) in paediatric wound care was discussed. The authors shared their experiences, thoughts, experimental data and clinical results. The panel identified the need for a product that can gently cleanse paediatric wounds and remove devitalised tissue without causing discomfort or skin reactions, as well as potentially promote healing. In adults, PMM has been shown to assist healing by hydrating the wound, controlling exudate and debriding non-viable tissue. Islands of neo-epithelium have also been reported to appear rapidly in different parts of the wound bed. No adverse effects on these proliferating cells have been observed. In vitro data suggest that PMM can remove biofilm, as well as potentially promote healing through cell salvage. The panel, therefore, set out to discuss their experiences of using PMM in the paediatric patients and to establish a consensus on the indications for its use and application in this population. This article will describe the main outcomes of that discussion and present case studies from paediatric patients with a variety of wound types, who were treated with PMM by members of the panel. Declaration of interest: This paper is based on a closed round table discussion held in November 2018. Medline Industries provided MA Healthcare with financial support to prepare the draft paper for publication. All of the authors, except GC, accepted an honorarium from Medline Industries for their participation. RSK, SLP and KDB have received research grants from Medline. RSK, RA, KDB, VB, PMG, SLP, MR, and TP are, or have been, consultants for Medline Industries. GC has no interests to declare.

KW - Cell repair

KW - Debridement

KW - Paediatric

KW - Pain reduction

KW - PluroGel

KW - Wound cleansing

KW - Wound healing

UR - http://www.scopus.com/inward/record.url?scp=85067033284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067033284&partnerID=8YFLogxK

U2 - 10.12968/jowc.2019.28.6.398

DO - 10.12968/jowc.2019.28.6.398

M3 - Article

C2 - 31166855

AN - SCOPUS:85067033284

VL - 28

SP - 398

EP - 408

JO - Journal of wound care

JF - Journal of wound care

SN - 0969-0700

IS - 6

ER -